Editorial: Interaction Between Modern Radiotherapy and Novel Drugs in Prostate Cancer: Future Perspectives

Beatrice Detti; Thomas Zilli; Gianluca Ingrosso; Ivone Ribeiro; Andrea Lancia

doi:10.3389/fonc.2022.876318

Editorial: Interaction Between Modern Radiotherapy and Novel Drugs in Prostate Cancer: Future Perspectives

Front Oncol. 2022 Mar 30:12:876318. doi: 10.3389/fonc.2022.876318. eCollection 2022.

Authors

Beatrice Detti¹, Thomas Zilli², Gianluca Ingrosso³, Ivone Ribeiro⁴, Andrea Lancia⁵

Affiliations

¹ Azienda Ospedaliera Universitaria Careggi, Radiotherapy Unit, Firenze, Italy.
² Radiation Oncology, Geneva University Hospital, Geneva, Switzerland.
³ Radiation Oncology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
⁴ Radiation Oncology, University Hospital of Gran Canaria Dr. Negrin Las Palmas de Gran Canaria, Las Palmas, Spain.
⁵ Radiation Oncology, San Matteo Hospital Foundation (IRCCS) Pavia, Pavia, Italy.

No abstract available

Keywords: Stereototactic Body Radiation Therapy (SBRT); androgen receptors inhibitors; metastasis-directed therapies (MDT); poly-ADP-ribose polymerase inhibitors (PARP-I); prostate-specific membrane antigen (PSMA) positron emission tomography.

Publication types

Editorial